Vivimed Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE526G01021
  • NSEID: VIVIMEDLAB
  • BSEID: 532660
INR
22.75
-1.19 (-4.97%)
BSENSE

Dec 23

BSE+NSE Vol: 9.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'23
Mar'22
Mar'21
Mar'19
Mar'18
Mar'17
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
16.58
16.58
16.58
341.73
341.73
16.20
Share Warrants & Outstandings
Total Reserve
22.84
347.70
414.99
602.07
884.67
718.01
Shareholder's Funds
39.42
364.29
431.58
943.79
1,226.40
734.21
Minority Interest
0.00
0.00
0.00
0.00
12.28
0.00
Long-Term Borrowings
62.32
60.99
57.79
424.80
325.20
453.31
Secured Loans
0.34
0.38
1.52
369.08
275.90
396.25
Unsecured Loans
61.98
60.61
56.27
55.72
49.30
57.06
Deferred Tax Assets / Liabilities
9.52
11.68
8.60
-6.79
-7.86
-6.46
Other Long Term Liabilities
448.41
447.3
443.57
62.43
32.49
54.82
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
4.38
8.36
6.72
9.21
7.03
2.19
Total Non-Current Liabilities
524.62
528.34
516.68
489.65
356.86
503.86
Current Liabilities
Trade Payables
69.41
41.89
34.25
294.42
201.99
178.59
Other Current Liabilities
37.39
33.05
38.10
262.21
202.52
256.91
Short Term Borrowings
316.25
297.89
267.82
332.30
385.16
381.47
Short Term Provisions
1.25
0.56
0.90
0.00
0.55
0.41
Total Current Liabilities
424.30
373.39
341.07
888.93
790.23
817.39
Total Liabilities
988.35
1,266.01
1,289.33
2,322.38
2,385.77
2,055.46
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
826.77
802.44
765.93
1,157.37
1,128.64
915.77
Less: Accumulated Depreciation
390.96
282.54
264.26
192.44
93.29
36.87
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
435.81
519.89
501.67
964.92
1,035.36
878.90
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
20.66
40.03
60.12
122.31
65.27
76.13
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
198.82
198.82
198.82
2.51
2.70
2.71
Long Term Loans & Advances
0.00
0.00
0.00
1.52
0.00
2.81
Other Non Current Assets
0.76
0.00
0.00
0.50
0.50
0.50
Total Non-Current Assets
656.06
758.75
760.62
1,091.77
1,103.83
961.04
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
79.76
240.77
255.68
563.69
540.17
483.97
Sundry Debtors
76.81
87.36
107.50
356.11
275.43
200.14
Cash and Bank
3.76
7.18
6.43
95.30
99.03
55.47
Other Current Assets
25.20
26.54
30.40
50.55
61.93
45.60
Short Term Loans and Advances
146.76
145.41
128.69
164.96
305.39
309.23
Total Current Assets
332.29
507.27
528.71
1,230.61
1,281.94
1,094.42
Net Current Assets (Including Current Investments)
-92.02
133.88
187.63
341.68
491.71
277.03
Total Current Assets Excluding Current Investments
332.29
507.27
528.71
1,230.61
1,281.94
1,094.42
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
988.35
1,266.01
1,289.33
2,322.38
2,385.77
2,055.46
Contingent Liabilities
122.93
215.57
220.66
55.52
160.87
236.89
Total Debt
378.57
358.88
325.62
757.10
710.36
834.78
Book Value per share (adjusted)
0.17
39.35
47.47
70.35
104.6
85.93
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2023 is 5.49% vs 10.21% in Mar 2022

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2023 is 0.25% vs 0.84% in Mar 2022

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2023 is -18.48% vs -0.33% in Mar 2022

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2023 is -34.49% vs -4.06% in Mar 2022

Compare Balance Sheet Results of Vivimed Labs.
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
16.58
83.40
-66.82
-80.12%
Share Warrants & Outstandings
Total Reserve
22.84
33,466.20
-33,443.36
-99.93%
Shareholder's Funds
39.42
33,549.60
-33,510.18
-99.88%
Minority Interest
0.00
377.80
-377.80
-100.00%
Long-Term Borrowings
62.32
380.00
-317.68
-83.60%
Secured Loans
0.34
0.00
0.34
0.00%
Unsecured Loans
61.98
380.00
-318.02
-83.69%
Deferred Tax Assets / Liabilities
9.52
-428.70
438.22
102.22%
Other Long Term Liabilities
448.41
651.80
-203.39
-31.20%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
4.38
29.80
-25.42
-85.30%
Total Non-Current Liabilities
524.62
632.90
-108.28
-17.11%
Current Liabilities
Trade Payables
69.41
2,647.80
-2,578.39
-97.38%
Other Current Liabilities
37.39
5,805.90
-5,768.51
-99.36%
Short Term Borrowings
316.25
3,804.50
-3,488.25
-91.69%
Short Term Provisions
1.25
775.60
-774.35
-99.84%
Total Current Liabilities
424.30
13,033.80
-12,609.50
-96.74%
Total Liabilities
988.35
47,594.10
-46,605.75
-97.92%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
826.77
36,759.60
-35,932.83
-97.75%
Less: Accumulated Depreciation
390.96
18,533.20
-18,142.24
-97.89%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
435.81
18,226.40
-17,790.59
-97.61%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
20.66
2,399.40
-2,378.74
-99.14%
Intangible assets under development
0.00
66.20
-66.20
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
198.82
720.40
-521.58
-72.40%
Long Term Loans & Advances
0.00
753.90
-753.90
-100.00%
Other Non Current Assets
0.76
409.70
-408.94
-99.81%
Total Non-Current Assets
656.06
22,576.00
-21,919.94
-97.09%
Current Assets Loans & Advances
Current Investments
0.00
3,330.70
-3,330.70
-100.00%
Inventories
79.76
7,108.50
-7,028.74
-98.88%
Sundry Debtors
76.81
9,042.00
-8,965.19
-99.15%
Cash and Bank
3.76
2,460.20
-2,456.44
-99.85%
Other Current Assets
25.20
886.60
-861.40
-97.16%
Short Term Loans and Advances
146.76
2,190.10
-2,043.34
-93.30%
Total Current Assets
332.29
25,018.10
-24,685.81
-98.67%
Net Current Assets (Including Current Investments)
-92.02
11,984.30
-12,076.32
-100.77%
Total Current Assets Excluding Current Investments
332.29
21,687.40
-21,355.11
-98.47%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
988.35
47,594.10
-46,605.75
-97.92%
Contingent Liabilities
122.93
0.00
122.93
0.00%
Total Debt
378.57
0.00
378.57
0.00%
Book Value per share (adjusted)
0.17
402.27
-402.10
-99.96%
Annual - Borrowings
Borrowings 378.57 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is 5.49% vs 10.21% in Mar 2022

Annual - Other Long Term Liabilities
Other Long Term Liabilities 448.41 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is 0.25% vs 0.84% in Mar 2022

Annual - Fixed Assets
Fixed Assets 456.48 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -18.48% vs -0.33% in Mar 2022

Annual - Investments
Investments 198.82 Cr
in Mar 2023

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 332.29 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -34.49% vs -4.06% in Mar 2022